STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more

Sanofi has settled an EU antitrust probe, paying a €218.5 million fine for abusing its dominant market position with its diabetes drug Lantus. The French pharmaceutical company has agreed to change its business practices to comply with EU competition rules.

The FTC has asked a U.S. court to hold 'pharma bro' Martin Shkreli in contempt for violating a court order banning him from working in the pharma industry. Shkreli was convicted in 2017 for securities fraud and is currently serving a seven-year prison sentence.